FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CUZZOCREA, S.
Right arrow Articles by SALVEMINI, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CUZZOCREA, S.
Right arrow Articles by SALVEMINI, D.
(The FASEB Journal. 2000;14:1061-1072.)
© 2000 FASEB

Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion

SALVATORE CUZZOCREA*1, THOMAS P. MISKO{dagger}, GIUSEPPINA COSTANTINO*, EMANUELA MAZZON{ddagger}, ANTONIO MICALI{ddagger}, ACHILLE P. CAPUTI*, HEATHER MACARTHUR§ and DANIELA SALVEMINI||

* Institute of Pharmacology and
{ddagger} Department of Biomorphology School of Medicine, University of Messina, Italy School of Medicine, University of Messina, Italy; G. D Searle,
{dagger} Discovery Pharmacology, St. Louis, Missouri 63167, USA;
§ Department of Pharmacological and Physiological Sciences, Saint Louis University School of Medicine, St. Louis, Missouri 63104, USA;
|| Metaphore Pharmaceuticals, St. Louis, Missouri 63110, USA

1Correspondence: Institute of Pharmacology, School of Medicine, University of Messina, Torre Biologica, Policlinico Universitario Via C. Valeria-Gazzi, 98100 Messina, Italy. E-mail: salvator{at}www.unime.it


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
The aim of the present study was to investigate the protective effect of the peroxynitrite decomposition catalyst 5,10,15,20-tetrakis(2,4,6-trimethyl-3,5-disulfonatophenyl)-porphyrinato iron (III) (FeTMPS) in a model of splanchnic artery occlusion shock (SAO). SAO shock was induced in rats by clamping both the superior mesenteric artery and the celiac trunk for 45 min, followed by release of the clamp (reperfusion). At 60 min after reperfusion, animals were killed for histological examination and biochemical studies. There was a marked increase in the oxidation of dihydrorhodamine 123 to rhodamine (a marker of peroxynitrite-induced oxidative processes) in the plasma of the SAO-shocked rats after reperfusion, but not during ischemia alone. Immunohistochemical examination demonstrated a marked increase in the immunoreactivity to nitrotyrosine, an index of nitrogen species such as peroxynitrite, in the necrotic ileum in shocked rats. SAO-shocked rats developed a significant increase of tissue myeloperoxidase and malonaldehyde activity, and marked histological injury to the distal ileum. SAO shock was also associated with a significant mortality (0% survival at 2 h after reperfusion). Reperfused ileum tissue sections from SAO-shocked rats showed positive staining for P-selectin localized mainly in the vascular endothelial cells. Ileum tissue sections obtained from SAO-shocked rats and stained with antibody to ICAM-1 showed a diffuse staining. Administration of FeTMPS significantly reduced ischemia/reperfusion injury in the bowel, and reduced lipid and the production of peroxynitrite during reperfusion. Treatment with PN catalyst also markedly reduced the intensity and degree of P-selectin and ICAM-1 staining in tissue sections from SAO-shocked rats and improved survival. Our results clearly demonstrate that peroxynitrite decomposition catalysts exert a protective effect in SAO and that this effect may be due to inhibition of the expression of adhesion molecules and the tissue damage associated with peroxynitrite-related pathways.—Cuzzocrea, S., Misko, T. P., Costantino, C., Mazzon, E., Micali, A., Caputi, A. P., Macarthur, H., Salvemini, D. Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion.


Key Words: SAO • polymorphonuclear leukocyte • cytokine • nitrate


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
OCCLUSION OF THE splanchnic circulation followed by reperfusion (SAO) results in a severe form of circulatory shock characterized by severe hypotension, hemoconcentration, intestinal injury, and a high mortality rate (1 , 2) . An important component of SAO shock is endothelial dysfunction (1 , 3 4 5) . In fact, a reduction in the ecNOS activity in reperfused intestine has been demonstrated by direct enzyme measurements by Kanwar and co-workers (6) .

The development of endothelial dysfunction was originally attributed to oxygen-derived free radicals released from both the reperfused endothelium (1 , 7) and activated adherent polymorphonuclear leukocytes (PMNs) (8 9 10 11) . The endothelial dysfunction (i.e., a deficit of endothelial nitric oxide production) predisposes to vasospasm, platelet deposition, and increased neutrophil adherence, which exacerbate the shock state.

Ischemia-reperfusion is a stimulus for leukocyte–endothelial interaction (12) . Loss of endothelial-derived nitric oxide (NO) is known to be one of the earliest manifestations of ischemia-reperfusion injury (13) , and this reduced NO is no longer able to significantly reduce leukocyte–endothelial interaction (14) . Leukocyte–endothelial interaction involves a complex system of adhesion molecules including the selectins, ß2 integrins, and the immunoglobulin superfamily (15 16 17) . Leukocyte interaction with the endothelium begins with leukocyte rolling, followed by adherence and transendothelial migration. P-selectin, a member of the selectin family of adhesion molecules, is believed to play a major role in the initial phase of leukocyte emigration, which is characterized by the rolling of leukocytes along the vascular endothelial surface. PMN rolling serves to tether the unstimulated neutrophil to activated endothelium, thus bringing the neutrophil in closer contact with adhesion-promoting substances such as platelet-activating factor (18) . Although P-selectin is necessary for early neutrophil contact with the endothelium, P-selectin-mediated leukocyte–endothelial interaction is not sufficient to allow neutrophil emigration from the vessel. A firmer adherence of the neutrophil to the endothelial surface is required for transendothelial migration (19) . This firm adherence involves the interaction of ß2 integrins (i.e., CD11/CD18) on the PMN surface and intercellular adhesion molecule 1 (ICAM-1) on the endothelial cell surface (19 , 20) . ICAM-1 has a molecular mass of 95 kDa (21) . The binding molecules for ICAM-1 in neutrophils and monocytes are the integrin ligands LFA-1 and Mac-1 (21 , 22) . De novo expression of ICAM-1 has been described in different cell types in inflammatory lesion, during rejection, and on melanoma cells (23 , 24) . Experimental studies have also showed that antibodies against ICAM-1 inhibit leukocyte adhesion to endothelial cells, granulocyte migration through endothelium, and mixed lymphocyte reactions in vitro (25 , 26) . In addition, in vivo administration of antibodies raised against ICAM-1 reduces neutrophil infiltration into the inflamed lungs in the rabbit and protects the development of SAO-induced injury.

Recent evidence suggests that peroxynitrite (ONOO-), a toxic oxidant formed from the reaction of NO and superoxide, is present in the reperfused heart (27 , 28) , liver (29) , kidney (30) , intestine (31) , brain (32) , and lung (33) . The biological activity and decomposition of peroxynitrite is dependent on the cellular or chemical environment (presence of proteins, thiols, glucose, the ratio of NO and superoxide, carbon dioxide levels, and other factors), and these factors influence its toxic potential (34) .

The cytotoxic effect of peroxynitrite toward the vascular endothelium has been directly demonstrated in reperfused hearts (27 , 28) and cultured human umbilical vein endothelial cells (35) . Therefore, in the presence of superoxide generators, agonist-induced release of NO from ecNOS exerts autocrine cytotoxic effects via the generation of peroxynitrite, which can be prevented by inhibition of endothelial NOS in vitro (36) . Last, data from in vivo/ex vivo experiments suggest that under certain conditions, e.g., during hypercholesterolemia and atherosclerosis (37) and during endotoxic shock (38) , endothelium-derived NO can combine with superoxide, and the resulting formation of peroxynitrite causes an impairment of the endothelial function. To date, the data generated to support the role of ONOO in vivo are indirect and have relied mainly on pharmacological (presumed inhibition of ONOO through reduction of NO by NOS inhibitors) and biochemical (measurement of rhodamine oxidation or nitrotyrosine formation as markers for ONOO-mediated reaction) approaches. To explore directly the role(s) of peroxynitrite in disease, we have used a class of porphyrin-containing compounds that catalytically decompose peroxynitrite to nitrate (39) . These catalysts do not react directly with either O2 or NO (39) and therefore can be used to assess the direct contributions of ONOO (39 40 41) . Catalysis is proposed to proceed via an oxo-Fe (IV) intermediate generated from the metal-promoted cleavage of the O-O bond. Subsequent recombination with NO2 regenerates the Fe(III) state and produces nitrate. These catalysts thus dramatically increase the rate of ONOO isomerization, preempting the formation of oxidizing radical species and generating the harmless nitrate anion. This mode of catalysis manifests itself by dramatic shifts in the resulting nitrite-to-nitrate ratio when compared with the proton-catalyzed decomposition (39 40 41 42) . Two of these catalysts, 5,10,15,20-tetrakis(2,4,6-trimethyl-3,5-disulfonatophenyl)-porphyrinato iron (III) (FeTMPS) and 5,10,15,20-tetrakis(2,4,6-trimethyl-3,5-disulfonatophenyl)-porphyrin iron (III) (FeTMPyP), were found to be effective both in vitro and in vivo at removing ONOO and preventing its cytotoxic effects resulting in potent antiinflammatory effects (40 , 41) . More important, pharmacological use of these catalysts allowed us to demonstrate for the first time that peroxynitrite indeed plays a key role in vivo in the development of ischemia and reperfusion. In the present study, we examined the protective effect of FeTMPS against oxidative stress during reperfusion of the splanchnic region after induced ischemia using both biochemical and morphological parameters.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Animals
Male Sprague-Dawley rats (250–300 g; Charles River; Milan; Italy) were housed in a controlled environment and provided with standard rodent chow and water. Animal care was in compliance with Italian regulations on protection of animals used for experimental and other scientific purpose (D.M. 116192) as well as with EEC regulations (O.J. of E.C. L 358/1 12/18/1986)

Surgical procedures
Male Sprague-Dawley rats weighing 250–300 g were allowed access to food and water ad libitum. The rats were anesthetized with sodium pentobarbital (45 mg/kg, intraperitoneal). After anesthesia, catheters were placed in the carotid artery and jugular vein as described previously (43) . Blood pressure was monitored continuously by a Maclab A/D converter (AD Instruments, Ugo Basile, Comerio (Ua), Italy), and stored and displayed on a Macintosh personal computer. After midline laparotomy, the celiac and superior mesenteric arteries were isolated near their aortic origins. During this procedure, the intestinal tract was maintained at 37°C by placing it between gauze pads soaked with warmed 0.9% NaCl solution. Rats were observed for a 30 min stabilization period before either splanchnic ischemia or sham ischemia. SAO shock was induced by clamping both the superior mesenteric artery and the celiac trunk, resulting in a total occlusion of these arteries for 45 min. After this period of occlusion, the clamps were removed. In one study, the various groups of rats were killed at 60 min for histological examination of the bowel and for biochemical studies, as described below.

Experimental groups
In the treated group of animals, ONOO decomposition catalyst was given as an intravenous (i.v.) bolus 10 mg/kg i.v injection 30 min before reperfusion (SAO+FeTMPS group). In a vehicle-treated group of rats, vehicle (saline) was given instead of ONOO decomposition catalyst (SAO group). In separate groups of rats, surgery was performed identically to the SAO group, except that the blood vessels were not occluded (time-controlled sham group, Sham). In an additional group of animals, SAO shock was combined with the administration of ONOO inactive catalyst compound (dose as above) (SAO+H2TMPS inactive decomposition catalyst).

Measurement of nitrite/nitrate in the plasma
Nitrite/nitrate levels, an indicator of NO synthesis, were measured in plasma samples from sham or SAO-shocked rats at 60 min after reperfusion as described previously (31) . First, nitrate in the plasma was reduced to nitrite by incubation with nitrate reductase (670 mU/ml) and NADPH (160 µM) at room temperature for 3 h. After 3 h, nitrite concentration in the samples was measured by the Griess reaction by adding 100 µl of Griess reagent (0.1% naphthalethylenediamine dihydrochloride in H2O and 1% sulfanilamide in 5% concentrated H3PO4; vol. 1: 1) to 100 µl samples. The optical density at 550 nm (OD550) was measured using a Spectramax 250 microplate reader (Molecular Devices Sunnyvale, Calif.). Nitrate concentrations were calculated by comparison with OD550 of standard solutions of sodium nitrate prepared in saline solution.

Measurement of peroxynitrite production
The formation of peroxynitrite was estimated by the peroxynitrite-dependent oxidation of dihydrorhodamine 123 to rhodamine, using a previously described method (31) . In separate groups, animals were injected with dihydrorhodamine 123 (2 µmol/kg in 0.3 ml saline i.v.) 40 min after reperfusion. Twenty minutes later, rats were killed and plasma samples were taken for rhodamine fluorescence evaluation using a Perkin-Elmer fluorometer (Model LS50B; Perkin-Elmer, Norwalk, Conn.) at an excitation wavelength of 500 nm, emission wavelength of 536 nm (slit widths 2.5 and 3.0 nm, respectively). The rate of rhodamine formation, an index of peroxynitrite production, was calculated using a standard curve obtained with authentic rhodamine (1–30 nM) prepared in plasma obtained from untreated rats. Background plasma fluorescence was subtracted from all samples.

Immunohistochemical localization of nitrotyrosine
Tyrosine nitration, an index of the nitrosylation of proteins by peroxynitrite and/or oxygen-derived free radicals, was determined by immunohistochemistry as described previously (31) . After reperfusion, tissues were fixed in 10% buffered formalin and 8 µm sections were prepared from paraffin-embedded tissues. After deparaffinization, endogenous peroxidase was quenched with 0.3% H2O2 in 60% methanol for 30 min. The sections were permeabilized with 0.1% Triton X-100 in phosphate-buffered saline (PBS) for 20 min. Nonspecific adsorption was minimized by incubating the section in 2% normal goat serum in PBS for 20 min. Endogenous biotin or avidin binding sites were blocked by sequential incubation for 15 min with avidin and biotin (DBA, Milan, Italy). The sections were then incubated overnight with 1:1000 dilution of primary anti-nitrotyrosine antibody (DBA) or with control solutions. Controls included buffer alone or nonspecific purified rabbit immunoglobulin G (IgG). Specific labeling was detected with a biotin-conjugated goat anti-rabbit IgG and avidin-biotin peroxidase complex (DBA).

Immunohistochemical analysis of P-selectin and ICAM-1
P-selectin and ICAM-1 localization was detected as described previously (44) in ileum sections by immunohistochemistry. After reperfusion, tissues were fixed in 10% buffered formalin; sections were permeabilized with 0.1% Triton X-100 in PBS for 20 min and incubated in 2% normal rat serum (for P-selectin evaluation) or hamster serum (for ICAM-1) for 2 h in order to minimize nonspecific adsorption. Sections were then incubated overnight 4°C with monoclonal biotinylated antibodies directed at P-selectin (rat anti-mouse CD62P) or ICAM-1 (hamster anti-mouse CD54) at dilution 1:500. Controls included buffer alone or nonspecific purified IgG. Antibody binding sites were visualized by an avidin-biotin peroxidase complex immunoperoxidase technique (Vector Laboratories, Burlingame, Calif.) using diaminobenzidine.

Immunocytochemistry photographs (n=5) were assessed by densitometry. The assay was carried out by using Optilab Graftek software on a Macintosh personal computer (CPU G3–266).

Myeloperoxidase (MPO) activity
MPO activity, an index of PMN accumulation, was determined as described previously (10) . Intestinal tissues, collected 60 min after reperfusion, were homogenized in a solution containing 0.5% hexa-decyl-trimethyl-ammonium bromide dissolved in 10 mM potassium phosphate buffer (pH 7) and centrifuged for 30 min at 20,000 g at 4°C. An aliquot of the supernatant was then allowed to react with a solution of tetra-methyl-benzidine (1.6 mM) and 0.1 mM H2O2. The rate of change in absorbance was measured by a spectrophotometer at 650 nm. MPO activity was defined as the quantity of enzyme degrading 1 µmol of peroxide min-1 at 37°C and was expressed in µunits per gram weight of wet tissue.

Leukocyte count
Tail vein blood samples for leukocyte count were taken at 60 min after reperfusion. The number of leukocytes (WBCx103/mm3) is shown as mean ± SD.

Malonaldehyde (MDA) measurement
Levels of MDA in the intestinal tissues were determined as an index of lipid peroxidation, as described by Okhawa et al. (45) . Intestinal tissues, collected 60 min after reperfusion, were homogenized in 1.15% KCl solution. An aliquot (100 µl) of the homogenate was added to a reaction mixture containing 200 µl of 8.1% sodium dodecyl sulfate, 1500 µl of 20% acetic acid (pH 3.5), 1500 µl of 0.8% thiobarbituric acid, and 700 µl distilled water. Samples were then boiled for 1 h at 95°C and centrifuged at 3000 g for 10 min. The absorbance of the supernatant was measured by spectrophotometry at 650 nm.

Measurement of cytokines
Tumor necrosis factor {alpha} (TNF-{alpha}) and interleukin 1ß (IL-1ß) levels were evaluated in plasma samples at 60 min after reperfusion. The assay was carried out by using a colorimetric commercial kit (Calbiochem-Novabiochem Corporation, San Diego, Calif.). The enzyme-linked immunoassay has a lower detection of 30 pg/ml.

Light microscopy
For histopathological examination, biopsies of small intestine were taken 60 min after reperfusion. The tissue were fixed in Dietric solution (14.25% ethanol, 1.85% formaldehyde, 1% acetic acid) for 1 wk at room temperature, dehydrated by graded ethanol, and embedded in Paraplast (Sherwood Medical, Mahwah, N.J.). From each biopsy, 7 µm thick sections were obtained, then stained with trichromic Van Gieson and studied using light microscopy (Dialux 22 Leitz).

Evaluation of survival
The various groups of rats were monitored for 4 h after SAO and reperfusion, and survival rates and survival times were evaluated.

Reagents
Biotin blocking kit, biotin-conjugated goat anti-rabbit IgG, and avidin-biotin peroxidase complex were obtained from Vector Laboratories. Primary anti-nitrotyrosine antibody was purchased from Upstate Biotech (Saranac Lake, N.Y.). Dihydrorhodamine 123 and rhodamine 123 were purchased from Molecular Probes (Eugene Oreg.). Peroxynitrite decomposition catalysts were prepared as described previously (39) .

Data analysis
All values in the figures and text are expressed as mean ± standard error of the mean of n observations, where n represents the number of animals studied. In experiments involving histology or immunohistochemistry, the figures shown are representative of at least three experiments performed on different experimental days. Data sets were examined by one- and two-way analysis of variance and individual group means were then compared with Student’s unpaired t test. Nonparametric data were analyzed with the Fisher’s exact test. A P value of less than 0.05 was considered significant.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Protective effects of peroxynitrite decomposition catalysts in splanchnic artery occlusion shock
Occlusion of the splanchnic arteries produced an increase in MAP, which then decreased until death (Fig. 1 ). The mean survival time was found to be 90 ± 5 min (n=27) whereas control sham animals survived for the entire period of observation (4 h, n=24; Table 1 ). Having established the survival time, in another series of experiments animals were killed either after the period of ischemia or 60 min post reperfusion in order to collect blood and tissues for biochemical analysis. Reperfusion of the ischemic splanchnic circulation led to a substantial increase in plasma lipid peroxidation products, as determined by increased levels of MDA (Fig. 2 ), TNF-{alpha}, and IL1ß (Fig. 3 ), and a profound infiltration of neutrophils into the intestine (the degree of infiltration was much more significant in the lungs than in the ileum by at least 10- to 15-fold) (Fig. 4 ). These inflammatory events were triggered by the reperfusion phase since no changes were observed when blood or tissues were removed after the period of ischemia alone (not shown).



View larger version (21K):
[in this window]
[in a new window]
 
Figure 1. The fall in mean arterial blood pressure (MAP) in SAO rats (n=6) is blocked by FeTMPS (10 mg/kg. n=6) but not by the inactive PN catalyst H2TMPS (10 mg/kg, n=4). Sham animals are represented (n=4).


View this table:
[in this window]
[in a new window]
 
Table 1. Effect of vehicle or FeTMPS on survival rate, percentage survival, and survival time in sham-shocked rats or splanchnic artery occlusion (SAO) shocked ratsa



View larger version (32K):
[in this window]
[in a new window]
 
Figure 2. Reperfusion of the ischemic splanchnic circulation leads to profound increase in plasma (A) and ileum (B) levels of MDA, and this is inhibited in a dose-dependent manner by FeTMPS (1–10 mg/kg) but not H2TMPS (10 mg/kg). Each point is the mean ±SE mean for n = 6 experiments. *P < 0.05 when compared to basal values. °P < 0.05 vs. IR.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 3. Reperfusion of the ischemic splanchnic circulation leads to profound increase in plasma TNF-{alpha} (A) and IL1ß (B), and this is inhibited in a dose-dependent manner by FeTMPS (1–10 mg/kg) but not H2TMPS (10 mg/kg). Each point is the mean ± SE mean for n = 6 experiments. *P < 0.05 when compared to basal values.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 4. Reperfusion of the ischemic splanchnic circulation leads to the infiltration of neutrophils in the ileum. FeTMPS significantly inhibit the neutrophils infiltration. Each point is the mean ±SE mean for n = 6 experiments. *P < 0.01 vs. vehicle. °P < 0.01 vs. SAO.

When given i.v 30 min prior to reperfusion, the active peroxynitrite decomposition catalyst FeTMPS (1–10 mg/kg, n=6), but not the inactive catalyst H2TMPS (10 mg/kg, n=6), inhibited in a dose-dependent manner the increased plasma and ileum levels of MDA (Fig. 2A, B ) as well as TNF-{alpha} and IL-1ß (Fig. 3) . FeTMPS significantly reduced the neutrophils infiltration into the ileum (Fig. 4) .

Therefore, FeTMPS (n=6) but not H2TMPS (n=6), both at 10 mg/kg, prevented the fall in blood pressure (Fig. 1) seen after reperfusion and increased the survival time (90±5% survival at 4 h in FeTMPS-treated rats vs. 0% survival at 4 h in untreated rats; Table 1 ).

NO and peroxynitrite production in splanchnic artery occlusion shock
There was no change in the plasma levels of nitrate/nitrite at 60 min of the reperfusion period (Fig. 5A ), in agreement with previous observations where we have demonstrated that the current protocol of ischemia and reperfusion does not trigger the expression of the inducible isoform of NOS (31 , 46) . Treatment with FeTMPS or H2TMPS did not affect baseline nitrite/nitrate levels (Fig. 5A ).



View larger version (34K):
[in this window]
[in a new window]
 
Figure 5. Plasma NOx levels (A); plasma peroxynitrite production assessed by oxidation of dihydrorhodamine 123 to rhodamine (B). There was no change in the plasma levels of nitrate/nitrite during occlusion or 60 min of reperfusion period. Peroxynitrite production in the SAO-shocked rats were significantly increased vs. sham group. FeTMPS-treated rats show a significant reduction of the SAO-induced elevation of the plasma peroxynitrite production. Values are means ± SE of 10 rats for each group. *P < 0.01 vs. vehicle. °P < 0.01 vs. SAO.

In agreement with previous observations (31 , 46) , SAO shock caused a significant increase in the rhodamine fluorescence of plasma, indicative of peroxynitrite-induced oxidation of dihydrorhodamine during the reperfusion phase (Fig. 5B ). In vivo treatment with FeTMPS reduced the oxidation of dihydrorhodamine 123 during reperfusion (Fig. 5B ).

At 60 min after reperfusion, ileum sections were taken from sham or shocked rats in order to determine the immunohistological staining for nitrotyrosine. Although there was negligible staining in the intestinal sections of control animals (Fig. 6A ), immunohistochemical analysis, using a specific anti-nitrotyrosine antibody, revealed a positive staining (14.23±1.2% of total tissue area) in ileum from SAO-shocked rats (see arrows; Fig. 6B ). In agreement with its effect on plasma dihydrorhodamine oxidation (Fig. 5B ), FeTMPS reduced the degree of immunostaining for nitrotyrosine (1.2±0.9% and 1.4±0.6 respectively of total tissue area) in the reperfused intestine (Fig. 6C ).



View larger version (103K):
[in this window]
[in a new window]
 
Figure 6. Immunohistochemical staining of nitrotyrosine was absent in ileum section from sham-operated rats (A). Sixty minutes after reperfusion nitrotyrosine staining was localized in the injured area (see arrows) from a SAO-shocked rats (B). There was no detectable immunostaining in the ileum from FeTMPS-treated rats (C). Original magnification: x500. Figure is representative of at least 3 experiments performed on different experimental days.

The inactive catalyst H2TMPS did not affect dihydrorhodamine oxidation (Fig. 6B ) or nitrotyrosine formation (data not shown).

Leukocyte count
The administration of FeTMPS did not modify the leukocyte count in sham-shocked rats. In contrast, SAO shock produced a marked leukopenia. Our data show that the leukocyte count was markedly decreased at 60 min after reperfusion. The administration of FeTMPS significantly ameliorated leukopenia (Table 2 ). In contrast, H2TMPS did not affect leukopenia (Table 2) .


View this table:
[in this window]
[in a new window]
 
Table 2. Effect of vehicle or ONOO catalysts on white blood cell count (WBC) of rats subjected to splanchnic artery occlusion (SAO) shocka

Immunohistochemical localization of P-selectin and ICAM-1 in the reperfused intestine
Ileum tissue section obtained from SAO-shocked rats undergoing 45 min of ischemia, followed by 1 h reperfusion, showed positive staining (3.026±0.04% of total tissue area) for P-selectin localized in the vascular endothelial cells of microvessels (see arrows Fig. 7B ). No staining was observed in sham-operated rats (Fig. 7A ). In tissue obtained from FeTMPS-treated rats, no up-regulation of P-selectin was found during ischemia and reperfusion (Fig. 7C ). Staining of ileum tissue sections obtained from sham-operated rats with anti-ICAM-1 antibody showed a specific staining along vessels, demonstrating that ICAM-1 is constitutively expressed (1.117±0.035% of total tissue area) in endothelial cells (see arrows; Fig. 8A ). After 1 h of reperfusion, the staining intensity increased substantially along vessels and in the necrotic tissues (6.07±0.052% of total tissue area) (Fig. 8B , arrows). Sections from FeTMPS-treated rats did not reveal any up-regulation of the constitutive ICAM-1 (Fig. 8C , arrow), which normally was expressed in the endothelium along the vascular wall (2.11±0.09%; of total tissue area). H2TMPS (inactive catalyst) did not affect adhesion molecule expression (data not shown).



View larger version (125K):
[in this window]
[in a new window]
 
Figure 7. Ileum section from sham-operated rats (A) revealed no P-selectin staining. Section obtained from SAO-shocked-rats showed intense positive staining for P-selectin (B) on venular endothelial cells (see arrows). The degree of endothelial staining was markedly reduced in tissue sections obtained from FeTMPS-treated rats (C). Original magnification: x500. Figure is representative of at least 3 experiments performed on different experimental days.



View larger version (97K):
[in this window]
[in a new window]
 
Figure 8. Control tissue from sham-operated rats (A) showed dark brown staining of endothelium of blood vessels, indicating the presence of constitutive ICAM-1 protein. Ischemia and reperfusion induced an increase of the positive staining for ICAM-1 along the endothelium wall (see arrows) (B). In FeTMPS-treated rats (C) subjected to SAO shock, there was no increase of immunostaining for ICAM-1, which was present only along the endothelium wall. Original magnification: x500. Figure is representative of at least 3 experiments performed on different experimental days.

Histological change
Histological examinations of the small intestine at 60 min of reperfusion (see Fig. 9 ) revealed pathological changes. Ileum section showed inflammatory infiltration (see arrows) by neutrophil and lymphocytes extending through the wall and concentrated below the epithelial layer (Fig. 9B ). FeTMPS-treated rats show a significant reduction in organ injury (Fig. 9C ). H2TMPS (inactive catalyst) did not affect ileum injury (data not shown).



View larger version (87K):
[in this window]
[in a new window]
 
Figure 9. Distal ileum section from a sham rats demonstrating the normal architecture of the intestinal epithelium and wall (A). Distal ileum section from SAO-shocked rats showed inflammatory infiltration by neutrophil and lymphocytes (see arrows) extending through the wall, concentrated below the epithelial layer, and demonstrating edema of the distal portion of the villi (B). Distal ileum from FeTMPS-treated rats shows reduced SAO-induced organ injury (C) Original magnification: x125. Representative of at least 3 experiments performed on different experimental days. M: mucosa; Mm: muscularis mucasae; Sm: submucosa; Mex: muscularis externa.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
A greater understanding of the role played by peroxynitrite in the pathogenesis of human disease will aid in the design of rational therapies for pharmacological intervention. Peroxynitrite is thought to posses a dual free radical nature capable of hydroxyl radical-like lipid peroxidation and NO2-driven nitration of tyrosine. Stability of ONOO is pH dependent, with protonation resulting in either decomposition into predominantly nitrate or the initiation of oxidative processes, including lipid peroxidation and the nitration of tyrosine. ONOO is a powerful oxidant that is highly reactive toward biological molecules, including protein and nonprotein sulfhydryls, DNA, and membrane phospholipids (34) . Peroxynitrite is also stable enough to cross several cell diameters to reach target cells before becoming protonated and decomposing (48) . It is therefore not surprising that evidence is increasing for a major role for peroxynitrite in the development of tissue damage during inflammation (49 , 50) as well as in human subjects during sepsis (51) . Nevertheless, as indicated earlier, implications for the participation of peroxynitrite in disease have relied on indirect evidence, mainly through the measurement of nitrotyrosine. The presence of nitrotyrosine at the site of injury does not prove, however, that peroxynitrite caused the damage, but simply that it is formed. Nitrotyrosine formation, along with its detection by immunostaining, was initially proposed as a relatively specific means for detection of the footprint of peroxynitrite (52) . Recent evidence indicates, however, that certain other reactions can also induce tyrosine nitration: the reaction of nitrite with hypochlorous acid and the reaction of MPO with hydrogen peroxide can lead to the formation of nitrotyrosine (53) . Increased nitrotyrosine staining is thus considered an indication of increased nitrosative stress rather than a specific marker of peroxynitrite. Our results using pharmacological agents specific for peroxynitrite decomposition (40 41 42) clearly indicate that peroxynitrite is the major cause of the intestinal damage after ischemia and reperfusion. FeTMPS and FeTMPyP, which have been shown to be active peroxynitrite decomposition catalysts (39 40 41) , protected against microvascular injury, lipid peroxidation, and epithelial cell injury. In addition, we have recently evidenced the efficacy of ONOO decomposition catalysts in vitro and in vivo (40 41 42) . At the cellular level, the catalyst FeTMPS was cytoprotective against exogenously added ONOO with an EC50 of {approx} 3.5 µM, a concentration almost 1/60th of the ONOO added. This protection correlated well with a reduction in the nitrotyrosine content of cellular proteins released after ONOO insult, an observation consistent with the proposed mechanism of action for these compounds. Moreover, we report that neither TMPS, an inactive structurally related compound, nor free Fe was cytoprotective (40 41 42) .

Our data demonstrate that FeTMPS treatment exerts an important protective effect against SAO shock. In fact, the present study provides evidence that 1) FeTMPS reduced the development of SAO-induced shock, 2) FeTMPS reduced morphological injury in SAO shock, 3) FeTMPS reduced lipid peroxidation, 4) in FeTMPS-treated rats subjected to occlusion and reperfusion of the splanchnic artery, up-regulation of P-selectin and ICAM-1 in the ileum was completely abolished, 5) FeTMPS reduced neutrophil infiltration, and 6) FeTMPS reduced cytokine production.

Endothelial cells appear to be major regulators of neutrophil traffic, regulating the process of neutrophil chemoattraction, adhesion, and emigration from the vasculature to the tissue. During the early phase of reperfusion, P-selectin is rapidly released to the cell surface from preformed storage pools after exposure to certain stimuli, such as hydrogen peroxide, thrombin, histamine, or complement, and allows the leukocytes to roll along the endothelium (16 , 20) . ICAM-1 constitutively expressed on the surface of endothelial cells is then involved in neutrophil adhesion (16 , 54) . Hypoxic endothelial cells synthesize proinflammatory cytokines, which can up-regulate endothelial expression of the constitutive adhesion molecule ICAM-1 in autocrine fashion (55) . Significant expression of ICAM-1 in microvessels of previously ischemic tissues occurs within 1 h after reperfusion (56) . The expression of P-selectin and ICAM-1 corresponds with the induction of neutrophil recruitment, which is maximal within the first hour of reperfusion and persists at a lower rate in the late phase of reperfusion (43 , 57) . In accordance with these findings, we observed that a 45 min occlusion of the splanchnic artery, followed by 1 h reperfusion, induced the synthesis of proinflammatory cytokines (TNF-{alpha} and IL-1ß) and the appearance of P-selectin on the endothelial vascular wall, and up-regulated the surface expression of ICAM-1 on endothelial cells. FeTMPS treatment reduced proinflammatory cytokines production (Fig. 3) and abolished the expression of P-selectin and the up-regulation of ICAM-1 (Fig. 4C , Fig. 5C ) while not affecting the constitutive levels of ICAM-1 on endothelial cells (data not shown). Numerous cell types release superoxide anions during the inflammatory response and these include endothelial cells, epithelial cells, macrophages, and neutrophils (58 , 59) . As seen here, neutrophils do infiltrate into the intestine and their activation at the site of injury may contribute to O2- production and subsequent damage. Recent evidence supports a damaging role of superoxide in the gastrointestinal tract (60) . Neutrophils are probably the main source for the release of superoxide and presumably play a major role in the generation of peroxynitrite.

Evidence that reactive nitrogen and oxygen species can exert proinflammatory properties includes recruitment of neutrophils at sites of inflammation, formation of chemotactic factors (58 , 59) , DNA damage, depolymerization of hyaluronic acid and collagen (61 , 62) , lipid peroxidation, and release of cytokines such as TNF-{alpha} and IL-1ß.

We can hypotheses that the mechanism of this peroxynitrite decomposition catalyst may be related to a prevention of peroxynitrite-induced endothelial injury as well as to the inhibition of reactive nitrogen and oxygen intermediates proinflammatory properties. In other words, we propose a positive feedback cycle in SAO shock (Fig. 10 ). Peroxynitrite decomposition catalyst would intercept this cycle at the level of endothelial injury and cytokine release. This model would explain the reduction of cytokine formation and the reduction of P-selectin and ICAM-1 and PMNs infiltration during reperfusion in the FeTMPS-treated rats.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 10. Proposed positive feedback cycle in SAO shock. Peroxynitrite decomposition catalyst would intercept this cycle at the level of endothelial injury and cytokine release. This model would explain the reduction of cytokine formation and the reduction of P-selectin and ICAM-1 and PMNs infiltration during reperfusion in the FeTMPS-treated rats.

In conclusion, we have directly demonstrated that peroxynitrite is associated with the intestinal damage evoked by ischemia and reperfusion. The peroxynitrite decomposition catalysts may offer a novel approach for manipulating the pathological sequelae that are associated with ischemia and reperfusion. The further use of these catalysts as pharmacological tools in animals models of human disease may lead to a better understanding of when and where peroxynitrite plays a key role(s) in the development of inflammatory diseases such as ischemia and reperfusion. This, in turn, should provide more effective treatment strategies in the clinic for disease. Peroxynitrite decomposition catalysts are not only useful tools for the pharmacological dissection of free radical-mediated pathology, but also offer promise as disease-modifying therapeutic agents capable of preserving the positive aspect of the double-edged sword of nitric oxide action.


   FOOTNOTES
 
Received for publication July 9, 1999. Revised for publication January 3, 2000.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Lefer, A. M., Lefer, D. J. (1993) Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu. Rev. Pharmacol. Toxicol. 33,71-90[Medline]
  2. Zimmermann, B. J., Arndt, H., Kubes, P., Kurtel, H., Granger, D. N. (1993) Reperfusion injury in the small intestine. Schlag, G. Redl, H. eds. Pathophysiology of Shock, Sepsis and Organ Failure ,322-335 Springer-Verlag Berlin.
  3. Altura, B. M., Gebrewolda, A., Burton, R. W. (1985) Reactive hyperaemic responses of single arterioles are attenuated markedly after intestinal ischemia, endotoxemia and traumatic shock: possible role of endothelial cells. Microcirc. Endothel. Lymph. 2,3-14
  4. Carey, C., Siegfried, M. R., Ma, S. L., Weyrich, A. S., Lefer, A. M. (1992) Antishock and endothelial protective actions of a NO donor in mesenteric and reperfusion. Circ. Shock 38,209-216[Medline]
  5. Zingarelli, B., Squadrito, F., Ioculano, M. P., Altavilla, D., Bussolino, F., Campo, G. M., Caputi, A. P. (1992) Platelet activating factor in splanchnic artery occlusion shock. Eur. J. Pharmacol. 222,13-19[Medline]
  6. Kanwar, S., Tepperman, B. L., Payne, D., Sutherland, L. R., Kubes, P. (1994) Time course of nitric oxide production and epithelial dysfunction during ischemia/reperfusion of the feline small intestine. Circ. Shock 42,135-140[Medline]
  7. Ratych, R. E., Chuknyska, R. S., Burkley, G. B. (1987) The primary localisation of free radical generation after anoxia/reoxygenation in isolated endothelial cells. Surgery 102,122-131[Medline]
  8. Granger, D. N., Rutili, G., McCord, J. M. (1981) Superoxide radicals in feline intestinal ischemia. Gastroenterology 81,22-23[Medline]
  9. McCord, J. M. (1981) Oxygen-derived free radicals in post ischemic tissue injury. N. Engl. J. Med. 312,159-163[Abstract]
  10. Mullane, K. M., Westlin, W., raemer, R. (1988) Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion. Ann. N.Y. Acad. Sci. 524,103-121[Abstract]
  11. Bittermann, H., Aoki, N., Lefer, A. M. (1988) Anti-shock effects of human superoxide dismutase in splanchnic occlusion shock. Proc. Soc. Exp. Biol. Med. 188,256-271
  12. Granger, D. N. (1977) Cell adhesion and migration. II. Leukocyte–endothelial cell adhesion in the digestive system. Am. J. Physiol. 273,G982-G986[Abstract/Free Full Text]
  13. Tsao, P. S., Aoki, N., Lefer, D. J., Johnson, G., Lefer, A. M. (1990) Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 82,1402-1412[Abstract/Free Full Text]
  14. Ma, X. L., Weyrich, A. S., Lefer, D. J., Lefer, A. M. (1993) Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ. Res. 72,403-412[Abstract/Free Full Text]
  15. Butcher, E. C. (1993) Specificity of leukocyte–endothelial interactions and diapedesis: physiologic and therapeutic implications of an active decision process. Res. Immunol. 144,695-698[Medline]
  16. Geng, J. G., Bevilacqua, M. P., Moore, K. L., McIntyre, T. M., Prescott, S. M., Kim, J. M., Bliss, G. A., Zimmerman, G. A., McEver, R. P. (1990) Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature (London) 343,757-760[Medline]
  17. von Andrian, U. H., Chambers, J. D., McEvoy, L. M., Bargatze, R. F., Arfors, K. E., Butcher, E. C. (1991) Two-step model of leukocyte–endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc. Natl. Acad. Sci. USA 88,7538-7542[Abstract/Free Full Text]
  18. Lorant, D. E., Patel, K. D., McIntyre, T. M., McEver, R. P., Prescott, S., Zimmerman, G. A. (1991) Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J. Cell Biol. 115,223-234[Abstract/Free Full Text]
  19. Butcher, E. C. (1992) Leukocyte-endothelial cell adhesion as an active, multi-step process: a combinatorial mechanism for specificity and diversity in leukocyte targeting. Adv. Exp. Med. Biol 323,181-194[Medline]
  20. Lawrence, M. B., Springer, T. A. (1991) Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 65,859-873[Medline]
  21. Marlin, S. D., Springer, T. A. (1987) Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51,813-819[Medline]
  22. Diamond, M. S., Staunton, D. E., Marlin, S. D., Springer, T. A. (1991) Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65,961-971[Medline]
  23. Johnson, K. J., Varani, J., Smolen, J. E. (1992) Neutrophil activation and function in health and disease. Immunol. Ser. 57,1-46
  24. Adams, D. H., Yannelli, J. R., Newman, W., Lawley, T., Ades, E., Rosenberg, S. A., Shaw, S. (1997) Adhesion of tumour-infiltrating lymphocytes to endothelium: a phenotypic and functional analysis. Br. J. Cancer 75,1421-1431[Medline]
  25. Boyd, A. W., Wawryk, S. O., Burns, G. F., Fecondo, J. V. (1988) Intercellular adhesion molecule-1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanism. Proc. Natl. Acad. Sci. USA 85,3095-3103[Abstract/Free Full Text]
  26. Dougherty, G. M., Murdoch, S., Hoggs, N. (1987) The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response. Eur. J. Immunol. 180,35-41
  27. Zingarelli, B., Cuzzocrea, S., Zsengeller, Z., Salzman, A. L., Szabó, D. (1997) Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc. Res. 36,205-215[Abstract/Free Full Text]
  28. Thiemermann, C., Bowes, J., Mynny, F. P., Vane, J. R. (1997) Inhibition of the activity of poly (ADP ribose) synthase reduces ischaemia-reperfusion injury in the heart and skeletal muscle. Proc. Natl. Acad. Sci. USA 94,679-683[Abstract/Free Full Text]
  29. Ma, T. T., Ischiropoulos, H., Brass, C. A. (1995) Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology 108,463-469[Medline]
  30. Yu, L., Gegaro, P. E., Niederberger, M., Burke, T. J., Schrier, R. W. (1994) Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc. Natl. Acad. Sci. USA 91,1691-1695[Abstract/Free Full Text]
  31. Cuzzocrea, S., Zingarelli, B., Costantino, G., Szabó, A., Salzman, A. L., Caputi, A. P., Szabó, C. (1997) Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br. J. Pharmacol. 121,1065-1074[Medline]
  32. Cazevieille, C., Muller, A., Meynier, F., Bonne, C. (1993) Superoxide and nitric oxide cooperation in hypoxia/reoxygenation-induced neuron injury. Free Rad. Biol. Med. 14,389-395[Medline]
  33. Kooy, N. W., Royall, J. A., Ye, Y. Z., Kelly, D. R., Beckman, J. S. (1995) Evidence for in vivo peroxynitrite production in human acute lung injury. Am. J. Resp. Crit. Care Med. 151,1250-1254[Abstract]
  34. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., Freeman, B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87,1620-1624[Abstract/Free Full Text]
  35. Szabó, C., Cuzzocrea, S., Zingarelli, B., O’Connor, M., Salzman, A. L. (1997) Endothelial dysfunction in endotoxic shock: importance of the activation of poly (ADP ribose) synthetase (PARS) by peroxynitrite. J. Clin. Invest. 100,723-735[Medline]
  36. Az-ma, T., Fujii, K., Yuge, O. (1996) Self-limiting enhancement by nitric oxide of oxygen free radical induced endothelial cell injury: evidence against the dual action of nitric oxide as hydroxyl radical donor/scavenger. Br. J. Pharmacol. 119,455-462[Medline]
  37. White, C. R., Brock, T. A., Chang, L. Y., Crapo, J., Briscoe, P., Ku, D., Bradley, W. A., Gianturco, S. H., Gore, J., Freeman, B. A. (1994) Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. USA 9,1044-1048
  38. Zingarelli, B., Day, B. J., Crapo, J., Salzman, A. L., Szabó, C. (1997) The potential involvement of peroxynitrite in the pathogenesis of endotoxic shock. Br. J. Pharmacol. 120,259-267[Medline]
  39. Stern, M. K., Jesen, M. P., Kramer, K. (1996) Peroxynitrite decomposition catalysts. J. Am. Chem. Soc. 118,8735-8736
  40. Misko, T. P., Highkin, M. K., Veenhuizen, A. W., Manning, P. T., Stern, M. K., Currie, M. G., Salvemini, D. (1998) Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J. Biol. Chem. 273,15646-15653[Abstract/Free Full Text]
  41. Salvemini, D., Wang, Z. Q., Stern, M. K., Currie, M. G., Misko, T. B. (1998) Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proc. Natl. Acad. Sci. USA 95,2659-2663[Abstract/Free Full Text]
  42. Salvemini, D., Jensen, M. P., Riley, D. P., Misko, T. B. (1998) Therapeutic manipulation of peroxynitrite. Drug News Prosp 4,204-214
  43. Caputi, A. P., Rossi, F., Carney, K., Brezenoff, H. E. (1980) Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats. J. Pharmacol. Exp. Ther. 215,309-316[Abstract/Free Full Text]
  44. Gauthier, T. W., Davenpeck, K. L., Lefer, A. M. (1994) Nitric oxide attenuates leukocyte–endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am. J. Physiol. 267,G562-G568[Abstract/Free Full Text]
  45. Ohkawa, H., Ohishi, N., Yagi, K. (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95,351-358[Medline]
  46. Cuzzocrea, S., Zingarelli, B., Caputi, A. P. (1998) Role of constitutive nitric oxide synthase activation and peroxynitrite production in a rat model of splanchnic artery occlusion shock. Life Sci 63,789-800[Medline]
  47. Salvemini, D., Manning, P. T., Zweifel, B. S., Seibert, K., Connor, J., Currie, M. G., Needleman, P., Masferrer, J. L. (1996) Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J. Clin. Invest. 96,301-308
  48. Crow, J. P., Beckman, J. S. (1995) The role of peroxynitrite in nitric oxide-mediated toxicity. Curr. Top. Microbiol. Immunol. 196,57-73[Medline]
  49. Cuzzocrea, S., Zingarelli, B., Gilard, E., Hake, P., Salzman, A. L., Szabó, C. (1998) Anti-inflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Rad. Biol. Med. 24,450-459[Medline]
  50. Salvemini, D., Wang, Z. Q., Wyatt, P., Bourdon, D. M., Marino, M. H., Manning, P. T., Currie, M. G. (1996) Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br. J. Pharmacol. 118,829-838[Medline]
  51. Fukuyama, N., Takebayashi, Y., Hida, M., Ishida, H., Ichimori, K., Nakazawa, H. (1997) Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock. Free Rad. Biol. Med. 22,771-774[Medline]
  52. Beckman, J. S. (1996) Oxidative damage and tyrosine nitration from peroxynitrite. Chem. Res. Toxicol. 9,836-844[Medline]
  53. Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B., Van Der Vliet, A. (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature (London) 391,393-397[Medline]
  54. Farhood, A., Mcguire, G. M., Manning, A. M., Miyasaka, M., Smith, C. W., Jaeschke, H. (1995) Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J. Leukoc. Biol. 57,368-374[Abstract]
  55. Shreeniwas, R., Koga, S., Karakurum, M., Pinsky, D., Kaiser, E., Brett, J., Wolitzky, B. C., Norton, C., Plocinski, J., Benjamin, W., Kurns, K. D., Goldestein, A., Stern, D. (1992) Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J. Clin. Invest. 90,2333-2339
  56. Clark, W. M., Lauten, J. D., Lessov, N., Woodward, W., Coull, B. M. (1995) Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia. Mol. Chem. Neuropathol. 26,213-230[Medline]
  57. Dreyer, W. J., Michael, L. H., West, M. S., Smith, C. W., Rothlein, R., Rossen, R. D., Anderson, D. C., Entman, M. L. (1991) Neutrophil accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localisation during early reperfusion. Circulation 84,400-411[Abstract/Free Full Text]
  58. Broner, C. W., Shenep, J. L., Stidham, G. L., Stokes, D. C., Hildner, W. K. (1988) Effect of scavengers of oxygen-derived free radicals on mortality in endotoxin-challenged mice. Crit. Care Med. 16,848-851[Medline]
  59. Henson, P. M., Johnston, R. B. (1987) Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J. Clin. Invest. 79,669-674
  60. Salvemini, D., Riley, D. P., Lennon, P. J., Wang, Z. Q., Currie, M. G., Macarthur, H., Misko, T. P. (1999) Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage. Br. J. Pharmacol. 127,685-692[Medline]
  61. Schraufstatter, I. U., Hinshaw, D. B., Hyslop, P. A., Spragg, R. G., Cochrane, C. G. (1986) Oxidant injury of cells: DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J. Clin. Invest. 77,1312-1320
  62. Henson, P. M., Johnston, R. B. (1987) Tissue injury and inflammation. Oxidants, proteinases and cationic proteins. J. Clin. Invest. 79,669-674



This article has been cited by other articles:


Home page
Physiol. Rev.Home page
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev, January 1, 2007; 87(1): 315 - 424.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Cuzzocrea, E. Mazzon, R. Di Paola, E. Esposito, H. Macarthur, G. M. Matuschak, and D. Salvemini
A Role for Nitric Oxide-Mediated Peroxynitrite Formation in a Model of Endotoxin-Induced Shock
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 73 - 81.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. Tentori, C. Leonetti, M. Scarsella, A. Muzi, E. Mazzon, M. Vergati, O. Forini, R. Lapidus, W. Xu, A. S. Dorio, et al.
Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma
FASEB J, August 1, 2006; 20(10): 1709 - 1711.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. L. Gookin, J. Allen, S. Chiang, L. Duckett, and M. U. Armstrong
Local Peroxynitrite Formation Contributes to Early Control of Cryptosporidium parvum Infection
Infect. Immun., July 1, 2005; 73(7): 3929 - 3936.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. Mollace, C. Muscoli, E. Masini, S. Cuzzocrea, and D. Salvemini
Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors
Pharmacol. Rev., June 1, 2005; 57(2): 217 - 252.
[Abstract] [Full Text] [PDF]


Home page